Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Insys Therapeutics, Inc.Listing unverified | Buy | $156.3K | conv 48ClusterFirst in 12mo | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $124.9K | conv 21 | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $22.6K | conv 21 | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $37.8K | conv 36First in 12mo | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $146.2K | conv 36First in 12mo | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $81.9K | conv 36First in 12mo | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $80.5K | conv 48Cluster | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $46.7K | conv 48Cluster | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $496.8K | conv 48Cluster | SEC | |
Insys Therapeutics, Inc.Listing unverified | Buy | $490.8K | conv 64ClusterFirst in 12mo | SEC | |
Insys Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Insys Therapeutics, Inc.Listing unverified | Other | $56.2M | SEC | ||
Insys Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Insys Therapeutics, Inc.Listing unverified | OtherD (derivative) | $56.2M | SEC |